跳至主要内容
临床试验/NCT04848246
NCT04848246已完成不适用

Efficacy of Smoking Cessation Interventions on Tuberculosis Treatment Outcomes Among Newly Diagnosed Pulmonary Tuberculosis Patients; a Single Blind Randomized Controlled Trial

Dow University of Health Sciences1 个研究点 分布在 1 个国家目标入组 292 人开始时间: 2017年11月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
292
试验地点
1
主要终点
Percentage of patients completing anti-tuberculosis treatment

研究概览

简要总结

This study was a Randomized Controlled Trial conducted at Ojha Institute of Chest Diseases, Dow University of Health Sciences, Karachi, among pulmonary tuberculosis patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

盲法说明

Outcome assessor for tuberculosis outcomes at the study site were blinded in terms of intervention allocation

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • pulmonary tuberculosis patients of age 18 years or above
  • registered under Directly Observed Treatment Short course (DOTS) at Ojha Institute of Chest Diseases
  • reported to have smoked 100 plus cigarettes in past and currently smoking cigarettes

排除标准

  • Extra pulmonary tuberculosis
  • drug resistant tuberculosis
  • pregnancy
  • positive history of epilepsy

研究组 & 干预措施

Bupropion

Experimental

干预措施: Bupropion (Drug)

Bupropion

Experimental

干预措施: Behavioural Change Communication (Behavioral)

Behavioural Change Communication

Experimental

干预措施: Behavioural Change Communication (Behavioral)

结局指标

主要结局

Percentage of patients completing anti-tuberculosis treatment

时间窗: six months

Among both smear positive and smear negative TB patients, successful completion of ATT will be labeled at the end of 6 months period if the patients has been compliant with ATT through six months period..

次要结局

  • Percentage of participants achieving abstinence from smoking(six months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Muhammad Tahir Rizwan Khan

Assistant Professor

Dow University of Health Sciences

研究点 (1)

Loading locations...

相似试验